Investors are always on the lookout for innovative biotech startups, and the Catalonia, Spain biopharma cluster has plenty to offer in the way of innovation from among its member companies. Biocat, the incubator for the growth of Catalonia’s BioRegion, comprises 824 companies which have brought over EUR 151 million in investment to Spain between 2013 and 2016.
In a feature story today, LaBiotech.eu, the leading digital media news outlet covering the European Biotech industry, five stellar biotech companies from Catalonia, ranging from clinical-stage biopharma to a non-profit academic research group, are profiled. Read the full article.
Barcelona has much to offer the biopharma community, and the strength of the cluster combined with Barcelona’s central European location are two of many reasons to consider investment opportunities there. BIO-Europe Spring®, the leading springtime life science partnering conference, will be held in Barcelona March 20–22, 2017 at the CCIB Convention Centre Barcelona. The event is expected to draw draw more than 2,400 pharma, finance and biotech executives seeking industry insight and partnerships.